Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.4988 | 98 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 10.4018 | 98 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 10.4975 | 98 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.5846 | 98 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.6872 | 98 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.70785 | 96 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.92747 | 97 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 9.21454 | 97 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.89834 | 96 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.9447 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 11.1873 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.9194 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 11.2235 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.8904 | 99 |